Erich L. Grimm

2.2k citations

39 papers · 1.7k indexed · h-index 19

Co-authors: Donald W. Nicholson Yongxin Han Sophie Roy Renée Aspiotis Steven Xanthoudakis Paul E. Swanson Richard S. Hotchkiss Kevin W. Tinsley
Topics: Cell death mechanisms and regulation (7 papers)Synthetic Organic Chemistry Methods (7 papers)Inflammatory mediators and NSAID effects (6 papers)
Cited by: Organic Chemistry Pharmacology Immunology
Journals: Journal of Neuroscience Nature Immunology Analytical Biochemistry
Partner nations: Canada United States Germany

In The Last Decade

Erich L. Grimm

38 papers receiving 1.6k citations

Peers

Countries citing papers authored by Erich L. Grimm

Since Specialization

Citations

This map shows the geographic impact of Erich L. Grimm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erich L. Grimm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erich L. Grimm more than expected).

Fields of papers citing papers by Erich L. Grimm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erich L. Grimm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erich L. Grimm. The network helps show where Erich L. Grimm may publish in the future.

Co-authorship network of co-authors of Erich L. Grimm

This figure shows the co-authorship network connecting the top 25 collaborators of Erich L. Grimm. A scholar is included among the top collaborators of Erich L. Grimm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erich L. Grimm. Erich L. Grimm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Design and synthesis of potent, isoxazole-containing renin inhibitors 2012 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),Elizabeth Cauchon,Austin Chen,Amandine Chefson,Yves Ducharme,Jean‐Pierre Falgueyret,Sébastien Gagné,Erich L. Grimm,Yongxin Han,Robert Houle,(unknown),Jean-François Lévesque,Dwight Macdonald,Bruce Mackay,(unknown),M. David Percival,Yeeman K. Ramtohul,(unknown),Sylvie Toulmond	9
2	3,4-Diarylpiperidines as potent renin inhibitors 2012 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),Renée Aspiotis,Elizabeth Cauchon,Austin Chen,Daniel Dubé,Jean‐Pierre Falgueyret,(unknown),Michel Gallant,Erich L. Grimm,Yongxin Han,Hélène Jûteau,(unknown),Christophe Mellon,Yeeman K. Ramtohul,(unknown),(unknown),Gavin Chit Tsui	6
3	The discovery and synthesis of potent zwitterionic inhibitors of renin 2011 ·Bioorganic & Medicinal Chemistry Letters ·Renée Aspiotis,Austin Chen,Elizabeth Cauchon,Daniel Dubé,Jean‐Pierre Falgueyret,Sébastien Gagné,Michel Gallant,Erich L. Grimm,Robert Houle,Hélène Jûteau,(unknown),(unknown),Jean-François Lévesque,Dwight Macdonald,(unknown),M. David Percival,Patrick Roy,S.M. Soisson,Tom Wu	7
4	Impact of passive permeability and gut efflux transport on the oral bioavailability of novel series of piperidine-based renin inhibitors in rodents 2011 ·Bioorganic & Medicinal Chemistry Letters ·Jean-François Lévesque,Kelly Bleasby,Amandine Chefson,Austin Chen,Daniel Dubé,Yves Ducharme,(unknown),Sébastien Gagné,Michel Gallant,Erich L. Grimm,Michael J. Hafey,Yongxin Han,Robert Houle,(unknown),(unknown),Dwight Macdonald,Bruce Mackay,Robert Papp,Richard A. Tschirret-Guth	9
5	Addressing time-dependent CYP 3A4 inhibition observed in a novel series of substituted amino propanamide renin inhibitors, a case study 2010 ·Bioorganic & Medicinal Chemistry Letters ·Austin Chen,Daniel Dubé,(unknown),Sébastien Gagné,Michel Gallant,(unknown),Erich L. Grimm,Robert Houle,(unknown),(unknown),(unknown),Dwight Macdonald,Bruce Mackay,David Martín,(unknown),David Powell,Jean-François Lévesque	12
6	Solid-phase analogue synthesis of caspase-3 inhibitors via palladium-catalyzed amination of 3-bromopyrazinones 2007 ·Bioorganic & Medicinal Chemistry Letters ·Élise Isabel,Renée Aspiotis,W. Cameron Black,John Colucci,Réjean Fortin,André Giroux,Erich L. Grimm,Yongxin Han,Christophe Mellon,Donald W. Nicholson,Dita Rasper,Johanne Renaud,Sophie Roy,John Tam,Paul Tawa,John P. Vaillancourt,Steven Xanthoudakis,Robert Zamboni	9
7	Substituted coumarins as potent 5-lipoxygenase inhibitors 2006 ·Bioorganic & Medicinal Chemistry Letters ·Erich L. Grimm,Christine Brideau,Nathalie Chauret,Chi‐Chung Chan,Daniel Delorme,Yves Ducharme,Diane Ethier,Jean‐Pierre Falgueyret,Richard W. Friesen,Jocelyne Guay,Pierre Hamel,Denis Riendeau,Chantal Soucy‐Breau,Philip Tagari,Yves Girard	44
8	Lipophilic versus hydrogen-bonding effect in P3 on potency and selectivity of valine aspartyl ketones as caspase 3 inhibitors 2005 ·Bioorganic & Medicinal Chemistry Letters ·Christophe Mellon,Renée Aspiotis,(unknown),Christopher I. Bayly,Erich L. Grimm,André Giroux,Yongxin Han,Élise Isabel,Daniel J. McKay,Donald W. Nicholson,Dita Rasper,Sophie Roy,John Tam,Nancy A. Thornberry,John P. Vaillancourt,Steven Xanthoudakis,Robert Zamboni	10
9	Inhibitors of the inducible microsomal prostaglandin E2 synthase (mPGES-1) derived from MK-886 2005 ·Bioorganic & Medicinal Chemistry Letters ·Denis Riendeau,Renée Aspiotis,Diane Ethier,Yves Gareau,Erich L. Grimm,Jocelyne Guay,Sébastien Guiral,Hélène Jûteau,Joseph A. Mancini,Nathalie Méthot,Joel Rubin,Richard W. Friesen	125
10	Solid phase synthesis of selective caspase-3 peptide inhibitors 2004 ·Bioorganic & Medicinal Chemistry ·Erich L. Grimm,Bruno Roy,Renée Aspiotis,Christopher I. Bayly,Donald W. Nicholson,Dita Rasper,Johanne Renaud,Sophie Roy,John Tam,Paul Tawa,John P. Vaillancourt,Steven Xanthoudakis,Robert Zamboni	12
11	Catalytic activity of caspase-3 is required for its degradation: stabilization of the active complex by synthetic inhibitors 2004 ·Cell Death and Differentiation ·Paul Tawa,Kai Hell,André Giroux,Erich L. Grimm,Yongxin Han,Donald W. Nicholson,Steven Xanthoudakis	91
12	3,4-Diaryl-5-hydroxyfuranones: highly selective inhibitors of cyclooxygenase-2 with aqueous solubility 2003 ·Bioorganic & Medicinal Chemistry Letters ·W. Cameron Black,Christine Brideau,Chi-Chung Chan,S. Charleson,Wanda Cromlish,Robert J. Gordon,Erich L. Grimm,Gregory Hughes,Serge Léger,(unknown),Denis Riendeau,Michel Thérien,Zhaoyin Wang,(unknown),Petpiboon Prasit	29
13	Discovery of novel aspartyl ketone dipeptides as potent and selective caspase-3 inhibitors 2003 ·Bioorganic & Medicinal Chemistry Letters ·Yongxin Han,André Giroux,Erich L. Grimm,Renée Aspiotis,(unknown),Christopher I. Bayly,Daniel J. McKay,Sophie Roy,(unknown),John P. Vaillancourt,Dita Rasper,John Tam,Paul Tawa,Nancy A. Thornberry,(unknown),Margarita García‐Calvo,Joseph W. Becker,J. Rotonda,Donald W. Nicholson,Robert Zamboni	23
14	Nicotinyl aspartyl ketones as inhibitors of caspase-3 2003 ·Bioorganic & Medicinal Chemistry Letters ·Élise Isabel,W. Cameron Black,Christopher I. Bayly,Erich L. Grimm,(unknown),Daniel J. McKay,Donald W. Nicholson,Dita Rasper,Johanne Renaud,Sophie Roy,John Tam,Nancy A. Thornberry,John P. Vaillancourt,Steven Xanthoudakis,Robert Zamboni	18
15	Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte 2000 ·Nature Immunology ·Richard S. Hotchkiss,K. Chang,Paul E. Swanson,Kevin W. Tinsley,Jiaojiao Hui,(unknown),Steven Xanthoudakis,Sophie Roy,Cheryl A. Black,Erich L. Grimm,Renée Aspiotis,Yongxin Han,Donald W. Nicholson,Irene E. Karl	452
16	Synthesis, characterization, and activity of metabolites derived from the cyclooxygenase-2 inhibitor rofecoxib (MK-0966, Vioxx™) 2000 ·Bioorganic & Medicinal Chemistry Letters ·Deborah A. Nicoll‐Griffith,James A. Yergey,Laird A. Trimble,José M. Silva,Chun Li,Nathalie Chauret,Jacques Yves Gauthier,Erich L. Grimm,Serge Léger,Patrick Roy,Michel Thérien,Zhaoyin Wang,Peppi Prasit,Robert Zamboni,Robert N. Young,Christine Brideau,Chi‐Chung Chan,Joseph A. Mancini,Denis Riendeau	33
17	A new structural variation on the methanesulfonylphenyl class of selective cyclooxygenase-2 inhibitors 1999 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),W. Cameron Black,Christine Brideau,(unknown),S. Charleson,Wanda Cromlish,David Claveau,(unknown),Robert J. Gordon,Gillian Greig,Erich L. Grimm,Jocelyne Guay,Cheuk K. Lau,Denis Riendeau,Michel Thérien,Denise M. Visco,Elizabeth Wong,Lijing Xu,Petpiboon Prasit	23
18	SAR in the alkoxy lactone series: the discovery of DFP, a potent and orally active COX-2 inhibitor 1999 ·Bioorganic & Medicinal Chemistry Letters ·Y. LEBLANC,Patrick Roy,S. Boyce,Christine Brideau,Chi-Chung Chan,S. Charleson,Robert J. Gordon,Erich L. Grimm,Jocelyne Guay,Serge Léger,(unknown),Denis Riendeau,Denise M. Visco,(unknown),J.K. Webb,Lijing Xu,Petpiboon Prasit	38
19	Facile construction of the bicyclo[6.4.0]dodecane ring system via intramolecular cyclization of a sulfone stabilized carbanion 1993 ·Tetrahedron Letters ·Erich L. Grimm,(unknown),Laird A. Trimble	11
20	Intramolekulare Diels-Alder-Reaktionen mit 2-Trimethylsiloxy-2-vinylcyclopropancarbonsäure-estern als Schlüsselbausteinen 1986 ·Angewandte Chemie ·(unknown),Erich L. Grimm,Hans‐Ulrich Reißig	6

About Erich L. Grimm

Erich L. Grimm is a scholar working on Organic Chemistry, Pharmacology and Biochemistry, having authored 39 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (7 papers), Synthetic Organic Chemistry Methods (7 papers) and Inflammatory mediators and NSAID effects (6 papers). The work is most often cited by research in Organic Chemistry (471 citations), Pharmacology (273 citations) and Immunology (304 citations). Erich L. Grimm has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include Donald W. Nicholson, Yongxin Han, Sophie Roy, Renée Aspiotis, Steven Xanthoudakis, Paul E. Swanson, Richard S. Hotchkiss, Kevin W. Tinsley, Cheryl A. Black and Irene E. Karl. Their work appears in journals such as Journal of Neuroscience, Nature Immunology and Analytical Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact